Cue Biopharma, Inc.
NASDAQ: CUE0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Lucinda Warren
- Employees
- 41
- Headquarters
- Boston, United States
- IPO year
- 2018
- Market cap
- $68.4M
- Website
- https://www.cuebiopharma.com
Loading CUE…
Loading profile data…Frequently asked questions about CUE
What does Cue Biopharma, Inc. (CUE) do?
Cue Biopharma, Inc. is a clinical-stage biopharmaceutical enterprise focused on creating biological therapies. Its central objective is the precise manipulation of the human immune system to address a spectrum of severe conditions, such as various cancers, chronic infectious diseases, and autoimmune disorders. The company's leading investigation...
Where does CUE trade?
Cue Biopharma, Inc. (CUE) trades on the NASDAQ Capital Market.
What sector is CUE in?
Cue Biopharma, Inc. (CUE) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Cue Biopharma, Inc.?
Lucinda Warren is the chief executive officer of Cue Biopharma, Inc. (CUE).
Where is Cue Biopharma, Inc. headquartered?
Cue Biopharma, Inc. is headquartered in United States.
Does CUE pay a dividend?
Cue Biopharma, Inc. (CUE) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CUE go public?
Cue Biopharma, Inc. (CUE) completed its initial public offering in 2018.